PRODUCT LITERATURE

Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: The Latin American Cohort

---

We compared the efficacy and safety of moxifloxacin and levofloxacin for the treatment of patients with acute exacerbations of chronic bronchitis (AECB) using a prospective, randomized, double blind, parallel-group clinical trial design. A total of 563 patients with AECB were enrolled (437 efficacy-valid) at 34 centers in Mexico, Argentina, Brazil, Colombia, and Peru. Patients were randomized to oral therapy with either moxifloxacin 400 mg once daily for 5 days or levofloxacin 500 mg
once daily for 7 days

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Molcin

Specific Detail Info

Respiratory Medicine (2006) 100, 1504–1511

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment